In this episode, Ayesha talked about a new at-home blood pressure monitor developed by Inbody that can track blood pressure in real time. The device uses the automated oscillometric method, commonly used in clinical settings now, to generate mean arterial pressure and calculate systolic and diastolic blood pressure from it using an algorithm. The device has a one-touch cuff and can be synced to Inbody’s mobile app, which allows users to access a digital health report outlining their blood pressure readings. This can help identify blood pressure fluctuations that could be indicative of heart conditions. The team discussed the convenience of at-home health monitoring and how it can allow individuals to better manage their health.The editorial team also discussed Eli Lilly’s nearly $1.5 billion investment into building new manufacturing facilities in the US and Ireland. The pharma giant said the investment will allow the company to expand its manufacturing capacities, particularly in light of new therapeutics it is developing in areas including Alzheimer’s, diabetes, cancer and autoimmune conditions. The pharma giant is anticipating an FDA approval for its Alzheimer’s drug donanemab this year. The new US site will be in North Carolina and the Irish plant will be in Limerick, both home to institutes, universities and companies involved in STEM-based research.Read the full articles here: InBody’s New At-Home Blood Pressure Machine Allows for Real Time MonitoringEli Lilly Announces Nearly $1.5 Billion Investment into New Manufacturing Facilities in North Carolina and IrelandFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured